James H. Campbell - 07 Mar 2022 Form 4 Insider Report for HANGER, INC.

Role
SVP, Chief Clinical Officer
Signature
/s/ Jessica Lochmann Allen, Attorney-in-Fact for James H. Campbell
Issuer symbol
N/A
Transactions as of
07 Mar 2022
Net transactions value
-$78,082
Form type
4
Filing time
08 Mar 2022, 18:11:18 UTC
Previous filing
16 Feb 2022
Next filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HNGR Common Stock Award $0 +6,283 +13% $0.000000 53,174 07 Mar 2022 Direct F1
transaction HNGR Common Stock Sale $78,082 -4,000 -7.5% $19.52 49,174 08 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HNGR Stock Options (right to buy) 27,328 07 Mar 2022 Common Stock 27,328 $12.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of time-based restricted stock under the Company's 2019 Omnibus Incentive Plan ("Plan"), which vests to the extent of 25% annually beginning on the first anniversary date of the grant and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 6,283 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2022.
F2 Stock options were granted under the Company's Special Equity Plan and vested 1/3 on each of May 19, 2018, 2019 and 2020.